ACTIVE ANKYLOSING SPONDYLITIS
Clinical trials for ACTIVE ANKYLOSING SPONDYLITIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE ANKYLOSING SPONDYLITIS trials appear
Sign up with your email to follow new studies for ACTIVE ANKYLOSING SPONDYLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease stiff spine pain for thousands
Disease control Recruiting nowThis study tests a new tablet called VC005 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 420 adults aged 18 to 70 will take the drug or a placebo for 12 weeks to see if it reduces symptoms by at least 20%. The goal i…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Arthritis drug xeljanz XR under Real-World safety watch
Disease control Recruiting nowThis study is tracking the safety and effectiveness of the arthritis drug Xeljanz XR in about 200 people in Korea who have moderate to severe rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Participants take the drug as part of their normal care, and researc…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 08, 2026 12:03 UTC